FK506-induced leukoencephalopathy in children with organ transplants

H. V. Torocsik, Richard G. Curless, J. Post, A. G. Tzakis, L. Pearse

Research output: Contribution to journalArticle

47 Scopus citations

Abstract

FK506-induced leukoencephalopathy is a well-known entity in adult organ transplant patients. The neurotoxicity of FK506 immunosuppression is frequently reversible, with either reduction or cessation of the drug. This neurologic syndrome is not well documented in children. We report the clinical and radiologic features in four pediatric cases of FK506 leukoencephalopathy. In two of the four patients this syndrome was reversible.

Original languageEnglish (US)
Pages (from-to)1497-1500
Number of pages4
JournalNeurology
Volume52
Issue number7
DOIs
StatePublished - Apr 22 1999

ASJC Scopus subject areas

  • Clinical Neurology

Fingerprint Dive into the research topics of 'FK506-induced leukoencephalopathy in children with organ transplants'. Together they form a unique fingerprint.

  • Cite this

    Torocsik, H. V., Curless, R. G., Post, J., Tzakis, A. G., & Pearse, L. (1999). FK506-induced leukoencephalopathy in children with organ transplants. Neurology, 52(7), 1497-1500. https://doi.org/10.1212/wnl.52.7.1497